Annual report pursuant to Section 13 and 15(d)

Note 4 - Acquisition - Summary of Consideration Transferred in Business Acquisition (Details)

v3.24.1.u1
Note 4 - Acquisition - Summary of Consideration Transferred in Business Acquisition (Details) - USD ($)
$ in Thousands
Jul. 01, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Goodwill   $ 731 $ 0 $ 0
Progressive Care [Member]        
Total purchase consideration $ 16,679      
Fair value of non-controlling interest 23,180      
Total consideration 39,859      
Cash 7,352      
Accounts receivable, net 6,478      
Accounts receivable, other 506      
Inventory 1,631      
Prepaid expenses 220      
Property and equipment, net 2,883      
Right of use assets, net 405      
Deposits 39      
Accounts payable and accrued expenses (8,231)      
Notes payable and accrued interest - current portion (149)      
Lease liabilities - current portion (208)      
Notes payable - long term (1,173)      
Lease liabilities - long term (230)      
Deferred tax liability (1) [1] 0      
Net assets acquired 25,233      
Goodwill 14,626      
Progressive Care [Member] | Trade Names [Member]        
Finite-Lived Intangibles 4,700      
Progressive Care [Member] | Developed Technology Rights [Member]        
Finite-Lived Intangibles 2,880      
Progressive Care [Member] | Pharmacy Records [Member]        
Finite-Lived Intangibles $ 8,130      
[1] Under federal tax law, previously unidentified finite lived intangible assets recognized from a business combination have no tax basis and therefore are not amortized for tax purposes. This tax position created a book/tax basis difference that was previously not recognized at July 1, 2023, the date of the business combination transaction. Therefore, an approximate $4.0 million deferred tax liability measurement period adjustment was recorded at December 31, 2023 as a result of the book/tax basis difference for the finite lived intangible assets. In addition the Company determined that the acquired deferred tax liability could be utilized to offset preexisting deferred tax assets. Therefore, in accordance with ASC 805-740-45-2, the Company released the deferred tax asset valuation allowance as a reduction to goodwill in the amount of approximately $4.0 million during the measurement period.